- Home
- RVNC vs NPCT Comparison
RVNC vs NPCT Comparison
Compare RVNC & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVNC
- NPCT
- Stock Information
- Founded
- RVNC 1999
- NPCT 2020
- Country
- RVNC United States
- NPCT United States
- Employees
- RVNC N/A
- NPCT N/A
- Industry
- RVNC Biotechnology: Pharmaceutical Preparations
- NPCT Investment Managers
- Sector
- RVNC Health Care
- NPCT Finance
- Exchange
- RVNC Nasdaq
- NPCT Nasdaq
- Market Cap
- RVNC 320.5M
- NPCT 320.0M
- IPO Year
- RVNC 2014
- NPCT N/A
- Fundamental
- Price
- RVNC $3.09
- NPCT $10.60
- Analyst Decision
- RVNC Hold
- NPCT
- Analyst Count
- RVNC 9
- NPCT 0
- Target Price
- RVNC $8.45
- NPCT N/A
- AVG Volume (30 Days)
- RVNC 3.6M
- NPCT 107.1K
- Earning Date
- RVNC 11-07-2024
- NPCT 01-01-0001
- Dividend Yield
- RVNC N/A
- NPCT 9.82%
- EPS Growth
- RVNC N/A
- NPCT N/A
- EPS
- RVNC N/A
- NPCT N/A
- Revenue
- RVNC $256,945,000.00
- NPCT N/A
- Revenue This Year
- RVNC $11.28
- NPCT N/A
- Revenue Next Year
- RVNC $27.21
- NPCT N/A
- P/E Ratio
- RVNC N/A
- NPCT N/A
- Revenue Growth
- RVNC 25.82
- NPCT N/A
- 52 Week Low
- RVNC $2.30
- NPCT $8.58
- 52 Week High
- RVNC $9.75
- NPCT $10.63
- Technical
- Relative Strength Index (RSI)
- RVNC 33.47
- NPCT 22.79
- Support Level
- RVNC $3.06
- NPCT $10.52
- Resistance Level
- RVNC $3.09
- NPCT $11.39
- Average True Range (ATR)
- RVNC 0.11
- NPCT 0.15
- MACD
- RVNC 0.02
- NPCT -0.08
- Stochastic Oscillator
- RVNC 6.90
- NPCT 8.17
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.